Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein
Vaccines · 31.05.2024 · 12 (6) · 604
DOI: 10.3390/vaccines12060604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 31.05.2024. Verfasst von Bin Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, No.12 East Wenhui Road, Yangzhou 225009, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Abstract (Originalsprache)
Newcastle disease (ND) is a significant infectious disease in poultry, causing substantial economic losses in developing countries. To control ND, chickens must be vaccinated multiple times a year. In order to develop an improved vaccine that provides long-term protection, the F gene from genotype VII NDV was inserted into the herpesvirus of turkey (HVT) vaccine virus using CRISPR/Cas9-mediated NHEJ repair and Cre/LoxP technology. The immunogenicity and protective efficacy of the resulting recombinant vaccines were evaluated through antibody assays and virus challenge experiments. Two recombinant vaccines, rHVT-005/006-F and rHVT-US2-F, were generated, both exhibiting growth rates comparable with those of HVT in vitro and consistently expressing the F protein. One-day-old specific pathogen-free (SPF) chickens immunized with 2000 PFU/bird of either rHVT-005/006-F or rHVT-US2-F developed robust humoral immunity and were completely protected against challenge with the NDV F48E8 strain at 4 weeks post-vaccination (wpv). Furthermore, a single dose of these vaccines provided sustained protection for at least 52 wpv. Our study identifies rHVT-005/006-F and rHVT-US2-F as promising ND vaccine candidates, offering long-term protection with a single administration. Moreover, HVT-005/006 demonstrates promise for accommodating additional foreign genes, facilitating the construction of multiplex vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ministry of Education Key Laboratory for Avian Preventive Medicine, Yangzhou University, No.12 East Wenhui Road, Yangzhou 225009, China.
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, No.12 East Wenhui Road, Yangzhou 225009, China.
ORCID-Profile: Kun Qian, Aijian Qin
Förderung
- Ministry of Science and Technology
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
Zitieren
APA
Shi, B., Yang, G., Xiao, Y., Qian, K., Shao, H., Xu, M., & Qin, A. (2024). Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein. Vaccines, 12(6), 604. https://doi.org/10.3390/vaccines12060604
Vancouver
Shi B, Yang G, Xiao Y, Qian K, Shao H, Xu M, et al. Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein. Vaccines. 2024;12(6):604. doi:10.3390/vaccines12060604
BibTeX
@article{Shi2024,
author = {Shi, Bin and Yang, Guifu and Xiao, Yue and Qian, Kun and Shao, Hongxia and Xu, Moru and Qin, Aijian},
title = {Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {6},
pages = {604},
doi = {10.3390/vaccines12060604}
}
EUVIMED